Menu Search
Equities

Microport Scientific Corp

MSK:FRA

Microport Scientific Corp

Actions
  • Price (EUR)0.685
  • Today's Change0.02 / 3.01%
  • Shares traded150.00
  • 1 Year change-65.58%
  • Beta--
Data delayed at least 15 minutes, as of Apr 26 2024 07:03 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MicroPort Scientific Corporation is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of medical products. The Company operates through seven segments. Orthopedics Devices segment researches, develops, manufactures and sells orthopedics devices. Cardiovascular Devices segment researches, develops, manufactures and sells cardiovascular devices, such as drug eluting stents. Endovascular Devices segment researches, develops, manufactures and sells endovascular devices. Electrophysiology Devices segment researches, develops, manufactures and sells electrophysiology devices. Neurovascular Devices segment researches, develops, manufactures and sells neurovascular devices. Surgical Management segment researches, develops, manufactures and sells surgical devices. Diabetes Care and Endocrinal Management segment researches, develops, manufactures and sells devices related to diabetes mellitus.

  • Revenue in HKD (TTM)7.44bn
  • Net income in HKD-3.74bn
  • Incorporated2006
  • Employees8.23k
  • Location
    Microport Scientific CorpNo. 1601 Zhangdong RoadZhangjiang Hi-Tech ParkSHANGHAI 201203ChinaCHN
  • Phone+86 2 138954600
  • Websitehttps://www.microport.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.